Market Research Blog – Page 15579 – New Product Development

Coronary Stents Market is expected to register a CAGR of 6.6% during the forecast period

Future Market Insights provides an in-depth analysis of the global coronary stents market in a new report titled “Coronary Stents Market: Global Industry Analysis and Opportunity Assessment, 2016-2026”. Coronary stents is a billion dollars industry that occupies a significant market share in the cardiovascular market. In terms of revenue, the global coronary stents market is estimated to reach a market valuation of US$ 6,002.9 Mn by 2016 end and is expected to register a CAGR of 6.6% during the forecast period. The global coronary stents market is expected to represent incremental opportunity of US$ 5,318.7 Mn between 2016 and 2026.

According to Future Market Insights, factors such as an increase in the prevalence of coronary artery disease, obesity, and minimal invasive procedures; and an increasing preference for advanced stenting procedures by cardiologists are some of the factors fuelling the growth of the global coronary stents market. Economic factors such as an increase in awareness campaigns about cardiovascular diseases conducted by government bodies, rapid progress in medical technology, and extended reimbursement support are also expected to boost the growth of the global coronary stents market over the forecast period.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1993

Segmentation highlights

The global coronary stents market is segmented on the basis of Product Type (Drug Eluting Stent, Bare Metal Stent, Bioresorbable Vascular Stent); Raw Material (Cobalt Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer); and End Use (Hospitals, Ambulatory Surgical Centres, Cardiac Catheterisation Laboratories).

The Drug Eluting Stent product type segment is estimated to be valued at US$ 8,750.2 Mn by 2026. The Bioresorbable Vascular Stent segment is estimated to account for 11.0% revenue share by 2016 end
The Polymer raw material segment is estimated to account for the highest market share of 29.2% by the end of 2016. The Cobalt Chromium segment is expected to register a CAGR of 5.6% during the forecast period
The Hospitals end use segment is anticipated to account for 70.9% value share of the global coronary stents market by the end of 2016. The Cardiac Catheterisation Laboratories segment is estimated to be valued at US$ 2,526.8 Mn by the end of 2026, registering a CAGR of 8.0% over the forecast period

Preview Coronary Stents Market Segmentation By Product Type – Drug Eluting Stent, Bare Metal Stent, Bioresorbable Vascular Stent; By Raw Material – Cobalt Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer; By End Use – Hospitals, Ambulatory Surgical Centres, Cardiac Catheterisation Laboratories: https://www.futuremarketinsights.com/checkout/1993

Regional projections

The global coronary stents market is segmented on the basis of region into North America, Latin America, Western Europe, Eastern Europe, APEJ, MEA, and Japan. The APEJ market is estimated to be valued at US$ 4,165.2 Mn by 2026, exhibiting a CAGR of 8% during the forecast period. The North America coronary stents market is expected to dominate the global coronary stents market in terms of revenue by 2016 end and is likely to retain its dominance throughout the forecast period.

The coronary stents market in North America is estimated to account for 29.2% market share of the global coronary stents market by 2016 end. The North America region is likely to be the second most attractive market with an attractiveness index of 2.5 during the forecast period. The markets in North America, Western Europe, and APEJ represent the highest growth opportunities in the global coronary stents market owing to a large patient population and an increasing demand for coronary stents in these regions.

Vendor insights

The global coronary stents market report profiles some of the top companies operating in the market. Leading market players featured in the report include Terumo Corporation, Boston Scientific Corporation, Medtronic, Vascular Concepts, B. Braun Melsungen AG, Biotronik SE & Co. KG, Abbott Laboratories, Biosensors International Group, Ltd., Hexacath, and Stentys SA. Key market players are focussing on increasing their footprints in emerging markets such as Asia Pacific and are expanding their manufacturing facilities and distribution network to gain a larger share of the global coronary stents market.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-1993

More from FMI’s Healthcare, Pharmaceuticals & Medical Devices:

Cardiac Surgery Devices Market Segmentation Product – Heart Lung Machine, Breathing Heart Surgery Systems(Stabilisers, Positioners), Catheters(Ablation Catheter, Drainage Catheter), Perfusion Disposables(Oxygenators, Centrifugal Pumps, Cardioplegia Delivery System); End User – Hospitals, Ambulatory Surgical Centres; Procedure – Coronary Artery Bypass Grafting(On pump CABG, Off pump CABG), Minimally Invasive Surgery
Outpatient Clinics Market Segmentation center type – single specialty centers, multi-specialty centers, diagnostics, surgical; specialty areas – cardiology, orthopedics, gastroenterology, dental, ophthalmology, urology, neurology, dermatology, other
Single-Photon Emission Computed Tomography Market segmentation by Product Type- Single Imaging, GammaCameras, SPECT/CT; Application Type- Cardiology, Oncology, Neurology, Others; End User- Hospitals, Diagnostic Imaging Centres, Ambulatory Surgical Centres

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/coronary-stents-market

Press Release Source: https://www.futuremarketinsights.com/press-release/coronary-stents-market

Positron Emission Tomography (PET) Scanners Market is projected to grow at a steady 5.1% CAGR from 2021 to 2031

Future Market Insights delivers key insights on the global Positron Emission Tomography scanners market in a new report titled, “Positron Emission Tomography (PET) Scanners Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”. In terms of revenue, the global Positron Emission Tomography (PET) scanners market is projected to register a healthy CAGR of 4.7% over the forecast period.

According to Future Market Insights, growing occurrences of chronic disorders and increasing penetration of PET machines is expected to drive overall growth of the global Positron Emission Tomography (PET) scanners market during the forecast period. Rising demand for effective diagnostic techniques across the globe and expanded applications for PET in the field of oncology are further expected to boost the growth of the global Positron Emission Tomography (PET) scanners market between 2016 and 2026. However, a short half-life and low supply of radiopharmaceuticals is likely to restrict market growth over the forecast period.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1333

“A key trend in the global Positron Emission Tomography (PET) scanners market is the development of dual modality PET/CT and PET/MRI machines leading to better diagnostic sensitivity and specificity at each stage of disease prognosis. The entry of new radiopharmaceuticals has enhanced the diagnostic value of diseases treatment resulting in greater dependency on PET scanning procedures. These trends are likely to govern the global Positron Emission Tomography (PET) scanners market in the coming years.” – Analyst – Healthcare, Pharmaceuticals & Medical Devices, Future Market Insights

positron emission tomography scanners market

Positron Emission Tomography Scanners Market

Segmentation highlights

The global Positron Emission Tomography (PET) scanners market has been segmented by Product Type (Full Ring PET Scanners, Partial Ring PET Scanners); by Application (Oncology, Cardiology, Neurology, Others); by Detector Type (Bismuth Germanium Oxide (BGO), Lutetium Oxyorthosilicate (LSO), Gadolinium Oxyorthosilicate (GSO), Lutetium Fine Silicate (LFS), Lutetium Yttrium Orthosilicate); and by End User (Hospitals, Diagnostic Centres, PET Centres, Research Institutes);

The Full Ring PET Scanners product type segment was valued at US$ 759.3 Mn in 2015 and is expected to register 4.8% CAGR over the forecast period. The Partial Ring PET Scanners product type segment was valued at US$ 143.8 Mn in 2015 and is expected to increase to US$ 212.2 Mn by the end of 2026
The Oncology application segment is estimated to account for 86.6% market share by 2016 while the Cardiology application segment is estimated to account for 5.0% market share by 2016 end. Both these segments are expected to be the most lucrative segments in the global Positron Emission Tomography (PET) scanners market during the forecast period
The Lutetium Oxyorthosilicate (LSO) detector type segment was valued at US$ 322.7 Mn in 2015 and is expected to witness a CAGR of 4.3% over the forecast period to reach US$ 596.5 Mn by 2026 end. The Bismuth Germanium Oxide (BGO) detector type segment was valued at US$ 266.7 Mn in 2015 and is expected to increase to US$ 400.5 Mn by the end of 2026
The Hospitals end user segment is estimated to hold 35.7% market share by 2016 end while the Diagnostic Centres end user segment is estimated to account for 33.0% market share by 2016 end

Regional market projections

The global Positron Emission Tomography (PET) scanners market has been segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, APEJ, MEA, and Japan. North America dominated the global Positron Emission Tomography (PET) scanners market in 2015 and is likely to continue its dominance throughout the forecast period. North America is expected to reach a market valuation of US$ 631.9 Mn by 2026 end, witnessing a CAGR of 4.8% over the forecast period. The APEJ Positron Emission Tomography (PET) scanners market is estimated to be valued at US$ 132.9 Mn by 2016 end and is expected to register a CAGR of 5.1% over the forecast period.

Vendor insights

General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., Siemens AG, Hitachi, Ltd., Positron Corporation, Mediso Ltd., and Yangzhou Kindsway Biotech Co. Ltd. are some of the leading players operating in the global Positron Emission Tomography (PET) scanners market. Major players in the global Positron Emission Tomography (PET) scanners market are focussing on enhancing their global and regional presence through introduction of novel products and strategic operational expansion. The report discusses individual strategies followed by these companies in terms of enhancing product designing, creating new manufacturing facilities, market consolidation, and advanced R&D initiatives.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1333

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Interleukin-6 (IL-6) Inhibitors Market Emerging Growth Analysis, Future Demand and Business Opportunities 2030

Interleukin-6 (IL-6) inhibitors are the inhibitors of cytokine Interleukin-6 (IL-6) to curb the diseases and symptoms induced by Interleukin-6 such as fever, inflammations, and autoimmune diseases including arthritis, asthma and cancer.

Interleukin-6 (IL-6) inhibitors are inhibitors of IL-6 and IL-6 receptors (IL-6Rs) to curb rheumatoid arthritis, Castleman’s disease (CD), cancers and asthma.

According to the World Health Organization, the globally 18% of women of above 80 years and 9.6% of men are suffering from arthritis. The American Cancer Society has stated the surge of 4,300 to 5,100 of CD in the U.S.

Coronavirus has surged the market of Interleukin-6 (IL-6) inhibitors with its demands to ameliorate severe pneumonia, alveolar damages. Tocilizumab and Sarilumab are in active use against Coronavirus and siltuximab are under investigation.

Current augmentations of improving healthcare industry, increasing therapeutic demands, active development of Interleukin-6 (IL-6) inhibitors and Coronavirus anticipates for the further future growth of global Interleukin-6 (IL-6) inhibitors.

Interleukin-6 (IL-6) Inhibitors Market: Drivers and Restraints

The driver of global Interleukin-6 (IL-6) inhibitors market includes the high target specificity and affinity of Interleukin-6 (IL-6) inhibitors and its availability, rising cases of rheumatoid arthritis, Castleman’s disease, cancer, arteritis and several other autoimmune and inflammatory diseases.

The global Interleukin-6 (IL-6) inhibitors market drivers include the availability of highly specific and efficient Interleukin-6 (IL-6) inhibitors, increasing autoimmune diseases and cancer, raising awareness, key market players, advancing research and healthcare expenditures.

The available Interleukin-6 (IL-6) inhibitors are highly efficient and target specific. Interleukin-6 (IL-6) inhibitors are primarily used for the treatment of Rheumatoid Arthritis, Castleman’s disease and cancers.

The positive outcomes of R&D, clinics trials and FDA approvals potentiate the lucrative growth spurt of Interleukin-6 (IL-6) inhibitors market, supported by government aids and awareness campaigns.

The manufactures and vendors are working with the key focus of improved efficacy, target specificities of the Interleukin-6 (IL-6) inhibitors, also strategic collaborations and alliances, and biologic development in the Interleukin-6 (IL-6) inhibitors domain are propelling the market.

However, the global Interleukin-6 (IL-6) inhibitors market decelerates by the adverse reactions, high cost and stringent regulations. Despite these restraints, the global Interleukin-6 (IL-6) inhibitors market is poised to grow lucratively by the supportive reimbursement policies for cutting down the cost and expenses, and the several potential including Olokizumab, Elsilimomab, Sirukumab, Clazakizumab and many more.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12570

Interleukin-6 (IL-6) Inhibitors Market: Overview

The global Interleukin-6 (IL-6) inhibitors market is poised to grow at a lucrative rate by the rising autoimmune diseases, improved Interleukin-6 (IL-6) inhibitors and advancing healthcare and research.

By disease type, Rheumatoid Arthritis dominates the segment with its rising cases and the active use of Interleukin-6 (IL-6) inhibitors (Tocilizumab) for treatment. By Interleukin-6 (IL-6) inhibitors type, the Tocilizumab rules the segment with its massive application for Rheumatoid arthritis, Systemic juvenile idiopathic arthritis Castleman’s disease (CD), giant cell arteritis and lung carcinomas.

Siltuximab segment is growing at a faster rate with its application for prostate cancer, renal cancer and CD. By distribution channels type, retail pharmacies segment holds the largest market of Interleukin-6 (IL-6) inhibitors distributions, driven by its convenience, drug availability and increasing numbers of retail pharmacies globally.

Interleukin-6 (IL-6) Inhibitors Market: Regional Outlook

North America leads the global Interleukin-6 (IL-6) inhibitors market with the increasing autoimmune diseases and cancer, supportive campaigns and programs for patients, recent Interleukin-6 (IL-6) inhibitors approvals and the key players.

Europe holds the second largest global Interleukin-6 (IL-6) inhibitors market due to the advanced healthcare infrastructure, expenditure and high demands. The Asia-Pacific Interleukin-6 (IL-6) inhibitors market are anticipated with further growth, driven by the rising awareness of diseases and treatments, advancing technology, healthcare and R&D.

Latin America Interleukin-6 (IL-6) inhibitors market is experiencing growth with the increasing research studies of Interleukin-6 (IL-6) inhibitors in the viral disease treatments. MEA & Africa is also growing with active research and clinical developments of Interleukin-6 (IL-6) inhibitors as therapeutics.

Interleukin-6 (IL-6) Inhibitors Market: Key players

The key players of global Interleukin-6 (IL-6) inhibitors market include

Roche
Sanofi
GlaxoSmithKline
Janssen
Tiziana Life Sciences
Regeneron
Novimmune
Vitaeris and Chugai Pharmaceutical.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12570

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Indication
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/12570

Interleukin-6 (IL-6) Inhibitors Market: Segmentation

The global Interleukin-6 (IL-6) inhibitors market is segmented into diseases, IL-6 inhibitors types, distribution channels and regions.

disease type:

Rheumatoid Arthritis
Castleman’s disease
Cancers (Renal cancer, prostate cancer )
Arteritis

IL-6 inhibitors types:

Tocilizumab
Siltuximab
Sylvant

distribution channels :

Retail Pharmacies
Hospital pharmacies
Online pharmacies

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Ventilator Market Challenges, Drivers, Outlook, Growth Opportunities – Analysis to 2030

There are various cases which requires the use of veterinary ventilators such as respiratory failures, drug toxicities, envenomation, congestive heart failure, pneumonia, tick paralysis and in various surgical procedures. Different types of ventilators are available to be used in small and large animals with technological functionality as mechanical, electronic, pneumatic and electro-pneumatic which can be used for the anesthesia and resuscitation purpose

Ventilator market players – Medtronic, Dickinson and Company, Becton, Getinge, Hamilton Medical, among others represent the global Ventilator market. The market study depicts an extensive analysis of all the players running in the Ventilator market report based on distribution channels, local network, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Ventilator Market report.

Future Market Insights, in its latest business report, elaborates on the current situation of the global Ventilator market in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1971

Covid-19 Impact on the Ventilators Market

Coronavirus has spread across 215 countries and territories and affected more than 35.6 million people, with close to 1 million deaths. Due to the COVID-19 outbreak, we estimate that the share of the infectious diseases segment has increased, and this segment is anticipated to grow significantly during the forecast period. COVID-19 has given momentum to the ventilators market. As a result, this market is expected to witness significant growth from 2020 to 2021

On the basis of end uses, the global Ventilator market study contains:

Ambulatory care centres
Emergency medical services
Hospitals & clinics

On the basis of Mode, the global Ventilator market report covers the key segments, such as

Combined-mode
Volume-mode
Pressure-mode

On the basis of Type, the global Ventilator market report covers the key segments, such as

Neonatal/infant ventilators
Paediatric/adult ventilators

On the basis of Mobility, the global Ventilator market report covers the key segments, such as

Intensive care ventilators
Critical care ventilators
Portable ventilators

What key insights does the Ventilator market research provide?

Historical and current year revenue of related Ventilator market players analyzed at the regional level.
One by one company profile of prominent stakeholders.
Analysis of the Ventilator market size on the basis of product type and end-use type.
Accurate Ventilator market forecast in terms of value and volume in numbers and percentages.
Demand prospect of each segment covered in the report.

Download Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-1971

The Ventilator market research gets rid of the following queries:

How the market for Ventilator is expected to shape in the coming ten years?
What strategies are the Ventilator market vendors implementing to stay ahead of their rivals?
Why are consumers shifting towards alternative Ventilator products?
What innovative technologies are the Ventilator players using to get an edge over their rivals?
What are the restraints affecting the growth of the global Ventilator market?

The Ventilator market study considers the following years to project the overall market growth:

History Year: 2015 – 2019
Base Year: 2019
Estimated Year: 2020
Forecast Year: 2020 – 2030

Key Features of Ventilator Market Report:

Overview, Industry Life Cycle Analysis, Supply Chain Analysis
Size, Trends, Growth Drivers, Constraints, SWOT Analysis, Forecast Analysis
Competitive Landscapes: Market Share, Product Portfolio, New Product Launches, etc.
Market attractiveness and Associated Growth Opportunities
Strategic Growth Opportunities for the Existing and New Players
Key Success Factors

Why choose Future Market Insights?

Modern technologies, such as artificial intelligence, to provide updated industry trends.
Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective.
Interaction with research scientists and development heads to understand the nature of the market more precisely.
Three-step quality check process – Data collection, triangulation, and validation.
24/7 availability of services.

Pre-Book Right Now for Exclusive Analyst Support@ https://www.futuremarketinsights.com/checkout/1971

Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape

Medical Ventilators Market FMI’s analysis gives an insight into key market trends, strategies, regional players and various segments on the basis of form, type, application and region.

Transportable Ventilator Market Find insights into global market scenario and segmentation on the basis of ingredients, application, source and region.

Veterinary Ventilators Market FMI’s report highlights parent market trends and strategies in the market with segments and dynamics through the forecast period.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com

Pancreatic Stone Protein Testing Market Key Manufacturers, Development Trends and Competitive Analysis 2029

Different pancreatic secretory proteins have been identified in the last decade. That is protein X, human pancreatic thread protein (PTP), and pancreatic stone protein (PSP). Among them, pancreatic stone protein has been reported to play a crucial role in the development of pancreatic stone. Pancreatic stone protein testing has been very useful for diagnosis and early management of stone formation in chronic pancreatitis. Pancreatic stone protein testing has been analyzed using several assay techniques such as ELISA, fluorometric immunoassay and enzyme immunoassay. A life-threatening syndrome is known as Sepsis resulting in multiple organ dysfunction. That is characterized by the deregulated host response to an infection. According to WHO sepsis affects more than 30 million people worldwide every year. Leading to 6 million deaths. The occurrence of sepsis is most likely highest in low- and middle-income countries. However, for the diagnosis of sepsis, pancreatic stone protein testing is showing great promises. Pancreatic stone protein has been used as a marker for the early detection and diagnosis of sepsis. Also, pancreatic stone protein has been used as a novel protein biomarker for the diagnosis of several other diseases related to pancreatic stone formation due to infection. Pancreatic stone protein testing is also helping in early diagnosis and management of diseases such as acute appendicitis and other wolfram syndromes such as diabetes insipidus, diabetes mellitus, optic atrophy etc.

Pancreatic Stone Protein Testing Market: Driver and Restraints

The increasing cases of chronic diseases due to pancreatic stone formation expected to drive the market of pancreatic stone protein testing. The prevalence of diseases such as acute appendicitis, diabetes and optic atrophy drives the pancreatic stone protein testing market worldwide. Change in lifestyle, increasing consumption of alcohol promotes acute pancreatitis, which expected to drive the pancreatic stone protein testing market. However, the symptoms of acute pancreatitis are nonspecific and biomarker such as pancreatic stone protein testing is high sensitivity and specificity are still lacking despite extensive research. Further, the cost-effectiveness, sensitivity, accuracy, and specificity of the pancreatic stone protein testing expected to restrain the pancreatic stone protein testing market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-10562

Pancreatic Stone Protein Testing Market: Overview

The market of pancreatic stone protein testing is very demanding globally because of its importance of used as a biomarker for the early detection of various life-threatening diseases. The symptoms of acute pancreatitis rate are higher in developing countries as well as in developed countries. Due to the change in lifestyles, irregular and unhealthy food consumption develops diseases such as sepsis, acute appendicitis and Wolfram syndrome worldwide. Consequently, the global market of pancreatic stone protein testing will expectedly grow vigorously in the near forecasting periods. The global key players have immense opportunity to develop assay kits and other immunoassay devices for the evaluation of pancreatic stone protein testing.

Pancreatic Stone Protein Testing Market: Region-wise Outlook

North America is expected as the leading market of pancreatic stone protein testing due to a greater degree of awareness among the individuals and high economy followed by Europe. Moderate growth of the pancreatic stone protein testing market will be expected in Asia Pacific countries due to the increasing rate of sepsis, acute appendicitis diseases and awareness among the people. Prominent growth of pancreatic stone protein testing market has been expected from the emerging countries such as China, India, Brazil and South Africa in the forecast years that will provide a huge opportunity to lunch new product among the market players.

Pancreatic stone protein testing Market: Key Market Participants

Ray Biotech, Inc., Thermo Fisher Scientific, Inc. Lifespan Biosciences Inc., Abnova Corporation, Amsbio LLC. (AMS Biotechnology (Europe) Ltd), CUSABIO TECHNOLOGY LLC, Boster Biological Technology, United States Biological Inc., Creative Diagnostics Inc., Abbexa Ltd., Aviva Systems Biology Corporation, among others.

The report covers exhaust analysis on:

Pancreatic Stone Protein Market Segments
Pancreatic Stone Protein Market Dynamics
Pancreatic Stone Protein Market Size
Pancreatic Stone Protein Supply & Demand
Pancreatic Stone Protein Current Trends/Issues/Challenges
Pancreatic Stone Protein Competition & Companies involved
Pancreatic Stone Protein Technology
Pancreatic Stone Protein Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (India, China ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-10562

Pancreatic Stone Protein Testing Market: Segmentation:

Based on techniques used, Pancreatic Stone Protein Testing market can be segmented as:

ELISA
Fluorometric Immunoassay

Based on Disease types, Pancreatic Stone Protein Testing market can be segmented as:

Sepsis
Acute Appendicitis
Diabetes
Diabetes Insipidus
Diabetes Mellitus
Optic Atrophy
Deafness

Based on the age group, Pancreatic Stone Protein Testing market can be segmented as:

Infant
Children
Adults
Geriatric

Based on end-users, the Pancreatic Stone Protein Testing market can be segmented as:

Hospitals
Speciality Clinics
Diagnostic Centers
Pathology Laboratories

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-10562

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

About Future Market Insights (FMI)

Antimicrobial Peptides Market Size, Analysis, Top Players, Target Audience and Forecast to 2029

Antimicrobial Peptides are molecules that form part of host defense mechanism in prokaryotic as well as eukaryotic cells capable of protecting against the harmful infective threats modelled by the bacteria, viruses and even fungi. The mode of action highly depends on the composition of antimicrobial peptides and hence utilized to target cytoplasmic membranes, cell walls, DNA and proteins. This makes antimicrobial peptides useful molecules to design assays, therapies and combination treatment via immunomodulation. The activation, elicitation and suppression of biological systems is gaining significant value in pharmaceutical as well as clinical applications to treat obscure oncological and rare maladies.

Antimicrobial Peptides Market: Drivers and Restraints

The cost of manufacturing antimicrobial peptides is more than the cost of manufacturing other pharmaceuticals for therapeutic utility depending on the target specificity. The business model for antimicrobial peptides is different than what is present in the pharmaceutical market owing to the novelty of the assays and techniques implemented.

The research process and designing the therapy process for commercialization is different, moreover the industry requires a more vigorous approach in order to create an entry and further access to the developing markets. Manufacturers of the antimicrobial peptides dependent therapy spend the majority their resources on upgrading the associated technology. The opportunities present in developing antimicrobial peptides are more as compared to threats prevalent. The application of antimicrobial peptides in ailment of Hepatitis C, pneumonia, bacterial infections, HIV AIDS and cancer is expected to surge the acceptance towards the therapies. The institutional research is heavily invested with rising pool of scientists and skilled technocrats interested in the domain for novel drugs involving antimicrobial peptides for rare diseases. The one of the pluses that include are antimicrobial peptides can be developed for a range of utilities ranging from increasing the shelf-life in food packaging to delivery of bioactive compounds in therapeutic sectors driving the market. The growing antibiotic resistance, synthetic approaches, innovative formulations and drug delivery routes are the factors expected to drive the growth.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-10249

Antimicrobial Peptides Market: Overview

The global market for antimicrobial peptides is estimated to experience a significant growth due to the increase in awareness and access towards drugs and therapies involving antimicrobial peptides. Chronic diseases where antibiotic resistance is not fruitful creates a more lucrative opportunity for manufactures present in the antimicrobial peptides market. The current structure of the antimicrobial peptides market include drugs targeted towards pneumonia, Hepatitis C, HIV and bacterial infections. Each of the antimicrobial peptides uses different type of mechanism and are used to deliver better clinical results.

Antimicrobial Peptides Market: Regional Outlook

Geographically, the Antimicrobial Peptides market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa. Each country is equally important to drive the market for antimicrobial peptides, advanced or emerging healthcare settings help in restoring the market and increase the reach to a wider section of patients in need. The distribution channel is an important part for antimicrobial peptides; the developed markets focus on the applications wherein the antimicrobial resistance is compromised whereas the emerging markets are more focused towards the reach and affordability of antimicrobial peptides. The North America region is estimated to have a significant share in the antimicrobial peptides market, owing to its quality infrastructure supporting the need of antimicrobial peptides research activities undertaken. It is followed by Europe, East Asia and Oceania. The South Asia antimicrobial peptides market would translate as a lucrative market opportunity for manufacturers, as well as industry experts, with present change in adoption and growth in general pharmaceutical market.

The key players involved in the market of antimicrobial peptides market include Eli Lilly and Company, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, EnBiotix Inc., Johnson & Johnson Services, Merck & Co., Alexion Pharmaceuticals, Inc., Melinta Therapeutics, Inc., and Vertex Pharmaceuticals, Inc. The present market structure of antimicrobial peptides is expected to change with efforts and research present in clinical phase.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

The report also maps the qualitative impact of various market factors on market segments and geographies.

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology Matrix
Value Chain

Regional analysis of the Antimicrobial Peptides market report includes

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-10249

Antimicrobial Peptides Market: Segmentation

Tentatively, the global antimicrobial peptides market has been segmented on the basis of ailments, distribution channel, route of administration and geography.

Based on ailments, the antimicrobial peptides market is segmented as:

Pneumonia
Hepatitis
Bacterial infections
HIV

Based on distribution channel, the global antimicrobial peptides market is segmented as:

Hospital
Research Institutes
Specialty Clinic
Pharmacies

Based on rote of administration, the global antimicrobial peptides market is segmented as:

Topical
Subcutaneous
Intravenous

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-10249

Antimicrobial Peptides Market Report Highlights:

Overview of Global Healthcare Market
Evolution of the technology
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

About Future Market Insights (FMI)

Electronic Tongue Market Key Insights, Profiling Companies and Growth Strategies by 2029

Electronic tongue is a device which measures and compares tastes. Electronic tongue is also called e-tongue. Electronic tongue equipped with multiple sensors which detect dissolved organic and inorganic compounds. Electronic tongue applies pattern recognition method to predict the taste of the sample. Electronic tongue has several application in various industries areas such as the pharmaceutical industry, food and beverage industry, and the healthcare industry. In the pharmaceutical industry, electronic tongue can be used for assessment of API bitterness strength and quantify bitterness of masking material. Electronic tongue is used to better adherence and improvement of taste of drugs for paediatric and geriatric patient base. Pharmaceutical companies have introduced the taste sensing systems for better development of paediatric and geriatric formulation. Electronic tongue is entered into medical diagnostic market and provide non-invasive disease diagnosis. The electronic tongue has used to detect and identify a wide array of disorders including mental health disorders and metabolic disorder by analyzing both liquid and vapour patient sample. Electronic tongue systems such as biomimetic cross-reactive sensor array are affordable and efficient for medical diagnosis.

Electronic Tongue Market: Drivers and Restraints-

Electronic tongue market is expected to accounts for a significant growth rate as technological advancement in the medical industry. Increasing demand for advanced and non-invasive diagnosis devices expected to favor the growth of the electronic tongue market. Growing research and development for new drugs manufacturing expected propel the growth of the electronic tongue market over the forecast period. Increasing adoption of advanced technologies and devices in pharmaceutical manufacturing units expected to ample the growth of the electronic tongue market. Increasing government funding for drug development and medical diagnosis producers advancement expected to boost up the growth of the electronic tongue market. Growing development of new devices and sensors for tastes assessment of dissolved organic and inorganic compounds favors the growth of the electronic tongue market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9409

Electronic Tongue Market: Overview

Electronic tongue market expected to grow with the significant growth rate over the forecast period as increasing demand for the electronic tongue in the pharmaceutical industry. Electronic tongue performs taste masking assessment and provide objective results. Electronic tongue performs taste assessment in a way similar to the human tongue. Electronic tongue analyzed sensory features such as the taste of drugs which is a key element in pharmaceutical product sales. Electronic tongue also detects gustatory components metallic, astringent and pungent with basic tastes such as sweet, bitter, salty, sour and umami. Electronic tongue enables pharmaceutical scientist to perform experiments without human safety consideration. Electronic tongue simplified the sensory test procedure for drug bitterness measurement.

Electronic Tongue Market: Region-wise Outlook

In terms of geography, the electronic tongue market has been divided into seven regions including Western Europe, North- America, Latin America, Eastern Europe, Japan, Middle-East & Africa, and Asia- Pacific excluding & Japan (APEJ). North America is expected to contribute the highest revenue share in the electronic tongue market as an increasing number of drug development and API formulation testing. Western European expected to contribute the second largest revenue followed by North America in electronic tongue market. Western Europe electronic tongue market expected to grow with major growth rate as increasing demand for advanced medical diagnostic devices. The Asia Pacific excluding Japan electronic tongue market is expected to grow with the highest growth rate over the forecast period due to increasing healthcare expenditure and growing investments in pharmaceutical developments.

Electronic Tongue Market: Key Market Participants

Example of companies participants in global electronic tongue market recognize across the value chain are Higuchi Inc., Norlab, Alpha MOS, TheSmartTongue, AFB International, Blonder Tongue Laboratories, Inc. and others. Manufactures are focusing on development of customized electronic tongue devices for medical and pharmaceutical industry.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9409

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (India, China ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Electronic Tongue Market: Segmentation

On the basis of application, electronic tongue market can be segmented as:

Medical Diagnosis
Drug Development
Scientific Research

On the basis of end user, electronic tongue market can be segmented as:

Pharmaceutical Companies
Contract Research Organization
Hospitals
Diagnostic Laboratories

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9409

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

About Future Market Insights (FMI)

Biopsy Device Market 2022 Industry Research, Segmentation, Key Players Analysis and Forecast to 2031

Over the 10-year forecast period 2021-2031, the global biopsy device market is estimated to witness a moderate yet promising CAGR of 5.2%, according to Future Market Insights. In a recently published report titled “Global Biopsy Device Market: Global Industry Analysis and Opportunity Assessment, 2021–2031” Future Market Insights analyses the market for biopsy device and offers key insights factors driving growth. Valued at around US$ 1,862.6 Mn in 2021, the market is forecast to surpass a valuation of US$ 3,089.2Mn by 2031-end.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1192

Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and biopsy device thereby.

biopsy device market characteristics and attributes with regional relevance, 2021-2031

Key Opportunities for Manufacturers and Suppliers:

Developing economies present lucrative, untapped markets for biopsy device.
Growing adoption of hybrid imaging technology will underpin new growth opportunities.
Following massive consumption by hospitals, demand for biopsy device from specific oncology centers and research institutes will prompt at multiple opportunities in near future.
Surging demand for minimal invasive breast biopsy highlights lucrative opportunities that lie in the breast cancer sector.
Increasing adoption of biopsy device by oncologists will generate several revenue generation opportunities in the disease monitoring sector.

Supported by increasing discretionary funding for cancer research, growing government expenditure for healthcare and favorable reimbursement scenario (especially in the U.S.) will collectively elevate the revenue sales of the global biopsy device market. Collaborations between various government and private companies, fuelled by increasing awareness about disease diagnosis and monitoring, will further elevate the market growth in near future.

M&A and Technological Upgrades Remain at the Forefront

A majority of key players in the global biopsy device market are currently focusing on providing innovative biopsy tests and technological upgrades. Mergers, acquisitions, and partnerships with diagnostic laboratories will help to strengthen their presence in the global market.

Among the top companies, Becton, Dickinson and Company is concentrating on innovative, cost-effective product development, whereas Hologic, Inc. is targeting manufacture and sales of biopsy devices, especially for breast cancer surgeries. Other notable players include Boston Scientific Inc., C. R. Bard, Inc., B. Braun Melsungen AG, Cook Medical, INRAD Inc., and PLANMED OY.

Argon Medical, one of the promising new entrants, is expanding its product portfolio and collaborating with established players, whereas for Devicor Medical Products Inc., M&A remains the key strategy.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1192

North America Remains the Most Lucrative Market

North America will remain the dominant market and is expected to surpass US$ 882 Mn by 2031 end, accounting for over 33% share of the market. Western Europe is expected to remain the second largest market for biopsy device, crossing a value of US$ 683 Mn by the end of 2031, capturing over 26% share of the market.

APEJ, with around 14% market value share in 2031, reaching a valuation of around US$ 370.0 Mn by the end of forecast period. MEA will register the fastest CAGR of 7.3%, followed by APEJ and Latin America with the respective CAGRs of 7.1% and 6.5% over 2021-2031. North America, Europe, and Japan will see moderate growth over the forecast period.

Biopsy Needles To Remain Top-selling Product Category

By product type, needles will remain dominant with over 36% share of the market value in 2031, whereas guns will represent the second largest sub-segment with over 26% market value share in 2031. With growing significance of early diagnosis of breast biopsy, guidance system segment is estimated to gain around 222 BPS in its market share by 2031 over 2021. Stereostatic X-ray guided biopsy will drive the guidance system segment through to 2031. Reagents and kits will witness moderate consumption.

Medical Diagnostics Monopolize Application Segment

Based on application type, medical diagnostics will continue to hold a dominant share of over 61% by 2031 end, in terms of revenues. Scientific research, accounting for the rest, will witness an impressively growing CAGR of 6.9% over 2021-2031. This segment is expected to reach beyond US$ 1,008.0 Mn in 2031.

Hospitals Remain Largest End-use Consumer

By end-user, hospitals will continue to contribute nearly 50% share to the market value by 2031 end. This end-use segment will witness a robust CAGR of 8.2%. Diagnostic centres will account for over 23% in 2031 with a slight decline over 2021-2031, whereas specialised oncology centres are anticipated to expand at a CAGR of 6.1% during 2021-2031.

Key Questions Answered in the Report

How much is biopsy device market worth?

What is the demand outlook for biopsy device market?

At what rate did market grow in the last five years?

What are the key trends shaping the biopsy device market?

What are the key factors driving biopsy device demand?

What is the market share of top 5 players?

What is the North America biopsy device market outlook?

Which country in Europe leads the biopsy device market?

Which are the top 5 countries driving demand for biopsy devices?

What is the biopsy device market statistics in South Korea and Japan?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/1192

Contact Us:

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Western Blotting Market 2022 Key Players, End User, Demand and Consumption by 2031

Rise in prevalence of AIDS coupled with the increase in research & development (R&D) activities in proteomics field continues to drive adoption of western blotting industry. According to the report titled “Global HIV & AIDS Statistics- 2020 Fact Sheet” published by the UNAIDS Organization, 38 million people globally were living with HIV in 2019, while 75.7 million people have become infected with HIV since the start of the epidemic (end 2019). These data represent the unlimited opportunities awaiting for suppliers and manufacturers in western blotting industry.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1050

Western blotting, being the gold standard and confirmatory test for HIV diagnosis, is gaining traction around the world. As the increase in applications in diverse fields such as agriculture, diagnostics, life science research, to name a few, tends to persist, manufacturers operating in this industry are getting more inclined to bring in wider variety of products. The updated edition of Future Market Insights’ study tracks growth in over 20+ markets, covering the regulatory framework as well as strategies of leading players.

According to Future Market Insights (FMI), the global western blotting market is expected to expand at close to 6.0% CAGR during the forecast period of 2021 to 2031.

Key Takeaways from Study

Electrophoresis blotting systems remain the preferred product type
Surge in demand from pharmaceutical and biotechnology sectors to fuel sales of western blotting products
Growing application in scientific research to favor stakeholders in western blotting industry
US will remain the most lucrative market for western blotting globally
Germany to maintain the lead in the world’s second largest western blotting market Europe
Asia-Pacific to witness the fastest growth rate, while being led by China, India, and Japan
The United Kingdom, France, Canada, Italy, and a few other countries remain lucrative for western blotting product manufactures

Rise in scientific research activities in proteomics, a rapidly growing field of molecular biology, is subject to cater to the steady expansion of the global western blotting market. Furthermore, increase in governmental investments in pharmaceutical & biotechnology sectors is expected to further cater to the growth of western blotting industry, says an FMI analyst.

Rise in Awareness Regarding Early Diagnosis of HIV Aiding Growth

Western blotting is highly efficient in separating the blood proteins and detecting the specific proteins called HIV antibodies in diagnosis of HIV or AIDS. According to a report published by the HIV Government on 25^th November, 2020, about 81% of people with HIV worldwide have been tested and know their HIV status. As per the report, an estimated 1.7 million individuals worldwide acquired HIV in 2019, marking a 23% decline in new HIV infections since 2010. While these figures represent the growing awareness, it also indicates the increase in requirement for western blotting products since the past decade.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1050

As stated in the global statistics report published by the HIV Government, AIDS-related deaths have been reduced by 60% since the peak in 2014, while in 2019, around 690,000 people died from AIDS-related illness worldwide, compared to 1.1 million in 2010. As per the report, the global commitment to stop new HIV infections and ensuring that everyone has access to HIV diagnosis & treatment is bound to yield positive results. This also implies the surge in demand for western blotting products in the coming years.

Who is Winning in this Space?

The global western blotting market offers remains fiercely competitive. In order to consolidate their position, key market players are launching wide variety of western blotting solutions.

For instance,

Thermo Fisher Scientific, Inc. launched its new range of western blotting products such as Thermo Fisher Electrophoresis Buffers and Reagents, Cell Lysis Buffers, Fluorescent Detection Solutions, and others a couple of years back
GE Healthcare launched its range of New Amersham™ WB System for Reproducible and Quantitative Protein Analysis, and other Western Blotting Solutions during 2014 to 2020

More Valuable Insights

In its latest report, FMI offers unbiased analysis of the global western blotting market, providing historical data for the period of 2016-2020 and forecast statistics for 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (electrophoresis blotting systems (automated dry blotting systems, semi-dry blotting systems, and traditional wet transfer blotting systems), and reagent kits (chromogenic reagent kits, chemiluminescent reagents kits (Horseradish Peroxidase (HRP) substrate, and Alkaline Phosphatase (AP) substrate), fluorescent reagents, antibodies (primary antibody, and secondary antibody), and buffer kits)), application (scientific research, medical diagnostics, agriculture, food & beverages, and others), and end use (diagnostic laboratories, research institutions, pharmaceutical & biotechnology companies), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Key Questions Answered in the Report

Which are the top companies operating in the Western Blotting Market?

Which are some of the lucrative markets for western blotting?

Which is a highly sought-after product type for western blotting?

Which are some key applications of western blotting?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/1050

Contact Us:

Peripheral Intravenous Catheter Market Key Players, SWOT Analysis, Key Indicators and Forecast

The global peripheral intravenous catheter market is expected to observe steady growth in 2016, reaching beyond US$ 3.8 Bn by 2016 end. Wide adoption of catheterisation techniques in patient examination, diagnosis, and treatment is anticipated to fuel the demand for PIVC. Rising disease prevalence will play a key role in driving the market growth. North America is likely to remain the largest market; Asia Pacific is expected to emerge at the fastest rate.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2558

Soaring disease prevalence will remain a prominent factor driving the demand for catheterisation, in turn pushing the market for PIVC. Apart from its usage in drug administration, increasing adoption of peripheral intravenous catheter in body fluid collection during a patient’s physical examination, is also identified to be a key driver to market growth. Prevalence of infections and epidemics are expected to further spur the demand for catheters in hospitals, clinics, ambulatory surgical centres, home healthcare units, and other healthcare centres. In addition to constantly enhancing healthcare infrastructure, the healthcare spending of consumers is also on the rise, which will favour the market growth.

Technological advancements in PIVC will particularly hold a positive impact on sales, boosting the market. Peripheral intravenous catheter is considered superior to its other counterparts, which will continue to drive adoption as a preferred option over other catheter types, eventually supporting the sales of PIVC. Moreover, there have been rising efforts toward manufacturing peripheral intravenous catheter using non-irritant, user-friendly material. Moreover, manufacturers are targeting PIVC design improvisation to eliminate the associated complications. This is projected to be a major factor positively influencing the market growth.

global peripheral intravenous catheter market_image for preview analysis

A few qualitative and technological complications associated with material composition, design, and after-effects of PIVC are expected to continue affecting mass adoption. In addition, market growth may be restricted due to expensive prices of peripheral intravenous catheter, especially in emerging economies. Conventional PIVC sales can also witness a drop owing to certain stringent medical device regulations in some of the developing countries.

By product, short peripheral intravenous catheter segment will remain dominant over integrated/closed peripheral intravenous catheter segment. Short PIVC segment is further sub-segmented into ported PIVC and non-ported PIVC. While short PIVC segment is expected to register the largest market share of over 71% in 2016, integrated/closed PIVC segment will witness significant Y-o-Y growth of 8.2%. Among the two sub-segments of short PIVC, non-ported PIVC is likely to remain dominant over ported PIVC.

On the basis of technology, safety peripheral intravenous catheter will continue to gain higher traction than conventional PIVC.

Based on end-user, hospitals segment is likely to generate the maximum PIVC demand. Ambulatory surgical units will also record decent demand. Peripheral intravenous catheter will register maximum revenue sales in 2016 in hospitals, accounting for over 60% market share. Ambulatory surgical units will remain the second most lucrative PIVC end-user segment.

By region, North America is expected to continue the leading position with around 45% share of the entire market revenues in 2016. Europe will continue to be the second largest market for PIVC with a value of over US$ 1.0 Bn in 2016. Asia Pacific is anticipated to emerge as the fastest growing region. Compared to a 5.8% of Y-o-Y of North America, APAC will witness a stronger Y-o-Y growth in 2017 over 2016.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-2558

Disease Prevalence and Frequent Epidemics Spur Demand for PIVC

Increasing disease prevalence and rising incidences of infection will continue to spur the demand for catheterisation in hospitals, healthcare centres, ambulatory surgical centres, clinics, and home healthcare units. Soaring frequency of disease epidemics is anticipated to generate substantial demand for peripheral intravenous catheters in order to accomplish patient examination, diagnosis, and treatment. This is likely to include a larger share of PIVCs, compared to other catheters.

Increasing Preference for Safety IV Catheters Primarily Drive Market

Increased spending on healthcare and advancements in healthcare infrastructure will continue to hold a positive influence on market growth. Moreover, the advent of PIVC technology will further boost the sales. Rising ability to afford expensive medical treatments, such as catheterization, will remain a key driver to market growth. User-friendly material composition of peripheral intravenous catheters compared to other counterparts, is another factor that makes them a preferred choice among physicians as well as patients.

Product Innovation Remains at the Centre Stage for Key Market Players

Key companies in the global peripheral intravenous catheter market are B. Braun Melsungen AG, Becton Dickinson and Company, Vygon Group, C. R. Bard, Inc., Smith Medical, Tangent Medical, and Terumo Corporation. B. Barun recently featured one of their latest product advancements – Ster-ASSIST™ i.e. Sterile Peripheral IV Catheter Insertion Kit (30th Association for Vascular Access (AVA) Annual Scientific Meeting).

Market Segmentation

To understand and assess opportunities in the global peripheral intravenous catheter market, we have divided the report into four sections based on market segmentation as under:

By Product Type

Short PIVC
Ported PIVC
Non-ported PIVC
Integrated/closed PIVC

By Technology

Conventional PIVC
Safety PIVC

By End-user

Hospitals
Ambulatory surgical centres
Clinics
Home use
Others

By Region

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/2558